Winton Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,468
| Closed | -$343K | – | 963 |
|
|
2022
Q1 | $343K | Sell |
5,468
-1,912
| -26% | -$120K | 0.02% | 785 |
|
|
2021
Q4 | $559K | Sell |
7,380
-874
| -11% | -$66.2K | 0.03% | 647 |
|
|
2021
Q3 | $924K | Buy |
+8,254
| New | +$924K | 0.05% | 546 |
|
|
2021
Q1 | – | Sell |
-5,770
| Closed | -$883K | – | 1384 |
|
|
2020
Q4 | $883K | Sell |
5,770
-15,702
| -73% | -$2.4M | 0.06% | 474 |
|
|
2020
Q3 | $1.8M | Sell |
21,472
-31,190
| -59% | -$2.61M | 0.06% | 577 |
|
|
2020
Q2 | $3.87M | Sell |
52,662
-30,330
| -37% | -$2.23M | 0.1% | 328 |
|
|
2020
Q1 | $3.52M | Buy |
82,992
+30,477
| +58% | +$1.29M | 0.09% | 384 |
|
|
2019
Q4 | $3.2M | Buy |
+52,515
| New | +$3.2M | 0.04% | 620 |
|